A discrete choice experiment to explore patients’ willingness to risk disease relapse from treatment withdrawal in psoriatic arthritis

por Rothery, Claire, Bojke, Laura, Richardson, Gerry, Bojke, Chris, Moverley, Anna, Coates, Laura, Thorp, Liz, Waxman, Robin, Helliwell, Philip
Publicado 2016

The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service

por Senay, A., Delisle, J., Giroux, M., Laflamme, G. Y., Leduc, S., Malo, M., Nguyen, H., Ranger, P., Fernandes, J. C.
Publicado 2016

Non-face-to-face treatment of stress urinary incontinence: predictors of success after 1 year

por Lindh, Anna, Sjöström, Malin, Stenlund, Hans, Samuelsson, Eva
Publicado 2016

Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and...

por Al-Daghri, Nasser M., Al-Saleh, Yousef, Aljohani, Naji, Sulimani, Riad, Al-Othman, Abdulaziz M., Alfawaz, Hanan, Fouda, Mona, Al-Amri, Fahad, Shahrani, Awad, Alharbi, Mohammed, Alshahrani, Fahad, Tamimi, Waleed, Sabico, Shaun, Rizzoli, Rene, Reginster, Jean-Yves
Publicado 2016

A new validated score for detecting patient-reported success on postoperative ICIQ-SF: a novel two-stage analysis from two large RCT cohorts

por Karmakar, Debjyoti, Mostafa, Alyaa, Abdel-Fattah, Mohamed
Publicado 2016

Gait speed and one-leg standing time each add to the predictive ability of FRAX

por Lundin, H., Sääf, M., Strender, L.-E., Nyren, S., Johansson, S.-E., Salminen, H.
Publicado 2016

Increased risk of hip fracture among spouses—evidence of a homogamy effect

por Vala, C. H., Odén, A., Lorentzon, M., Sundh, V., Johansson, H., Karlsson, M., Rosengren, B., Ohlsson, C., Johansson, B., Kanis, J., Mellström, D.
Publicado 2016

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

por Wozniak, L. A., Johnson, J. A., McAlister, F. A., Beaupre, L. A., Bellerose, D., Rowe, B. H., Majumdar, S. R.
Publicado 2016

Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus

por Pereira, M., Gohin, S., Lund, N., Hvid, A., Smitham, P. J., Oddy, M. J., Reichert, I., Farlay, D., Roux, J. P., Cleasby, M. E., Chenu, C.
Publicado 2016

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

por Khan, A. A., Hanley, D. A., Rizzoli, R., Bollerslev, J., Young, J.E.M, Rejnmark, L., Thakker, R., D’Amour, P., Paul, T., Van Uum, S., Shrayyef, M. Zakaria, Goltzman, D., Kaiser, S., Cusano, N. E., Bouillon, R., Mosekilde, L., Kung, A. W., Rao, S. D., Bhadada, S. K., Clarke, B. L., Liu, J., Duh, Q., Lewiecki, E. Michael, Bandeira, F., Eastell, R., Marcocci, C., Silverberg, S. J., Udelsman, R., Davison, K. Shawn, Potts, J. T., Brandi, M. L., Bilezikian, J. P.
Publicado 2016

Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects

por Rosengren, B. E., Björk, J., Cooper, C., Abrahamsen, B.
Publicado 2016

Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledro...

por Nakamura, T., Fukunaga, M., Nakano, T., Kishimoto, H., Ito, M., Hagino, H., Sone, T., Taguchi, A., Tanaka, S., Ohashi, M., Ota, Y., Shiraki, M.
Publicado 2016

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group

por Fleischmann, R, Mease, PJ, Schwartzman, S, Hwang, L-J, Soma, K, Connell, CA, Takiya, L, Bananis, E
Publicado 2016

The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study

por An, Yuan, Liu, Tian, He, Dongyi, Wu, Lijun, Li, Juan, Liu, Yi, Bi, Liqi, Zhou, Bin, Lin, Changsong, He, Lan, Liu, Xiangyuan, Li, Xiaofeng, Yang, Niansheng, Zhang, Zhuoli, Song, Hui, Wei, Wei, Liu, Jing, Bi, Yu, Li, Zhanguo
Publicado 2016

Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors

por Layh-Schmitt, Gerlinde, Lu, Shajia, Navid, Fatemeh, Brooks, Stephen R., Lazowick, Emily, Davis, Kathryn M., Montagna, Cristina, Gadina, Massimo, Colbert, Robert A.
Publicado 2016

Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women

por Kharroubi, Akram, Saba, Elias, Smoom, Riham, Bader, Khaldoun, Darwish, Hisham
Publicado 2017

Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractur...

por Mathavan, N., Tägil, M., Isaksson, H.
Publicado 2016

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

por Kamimura, M., Nakamura, Y., Ikegami, S., Uchiyama, S., Kato, H., Taguchi, A.
Publicado 2016

Low-level laser therapy (LLLT) does not reduce subcutaneous adipose tissue by local adipocyte injury but rather by modulation of systemic lipid metabolism

por Jankowski, Marek, Gawrych, Mariusz, Adamska, Urszula, Ciescinski, Jakub, Serafin, Zbigniew, Czajkowski, Rafal
Publicado 2016

Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis

por Narayan, Nehal, Rigby, Shirley, Carlucci, Francesco
Publicado 2016